-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of lessee's right to use underlying asset under operating lease.
-
Summary
-
NeuroSense Therapeutics Ltd. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2022 to Q2 2024.
- NeuroSense Therapeutics Ltd. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $123K.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)